Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EMAX Solution Partners was a specialized provider of revenue management and compliance software solutions for the life sciences industry. The company focused on helping pharmaceutical and biotech manufacturers manage complex contracting, pricing, and government rebate obligations, including Medicaid and 340B programs. Its technology was designed to automate financial processes and ensure regulatory adherence in a highly scrutinized market. In 2006, EMAX was acquired by I-many, Inc. for approximately $27 million, integrating its capabilities into a broader suite of enterprise contract management tools. The company's legacy continues through the evolution of its technology into the Revitas and subsequently Model N platforms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EMAX Solution Partners.